ena-STUDY-RIVM-23-07-2020-14:21:46:233-1824
Nationwide surveillance pilot study of carbapenemase-producing Pseudomonas aeruginosa unveils a multi-hospital clonal outbreak of VIM-2-positive ST111 in the Netherlands between 2015-2017.
Nationwide surveillance pilot study of carbapenemase-producing Pseudomonas aeruginosa unveils a multi-hospital clonal outbreak of VIM-2-positive ST111 in the Netherlands between 2015-2017.